Birmingham biotech startup Soluble Therapeutics has been acquired in a multimillion-dollar deal. San Antonio-based CytoBiosciences secured the purchase on Nov. 1, the company announced Wednesday, and plans to move Soluble's eight employees to Texas within the next year. "Combining forces with CytoBioscience will dramatically increase our business, as it will provide additional service opportunities to our existing customers," said Sharney Logan, managing director of Soluble Therapeutics, in...